Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-191149
Filing Date
2020-07-10
Accepted
2020-07-10 16:54:30
Documents
6
Period of Report
2020-07-10

Document Format Files

Seq Description Document Type Size
1 6-K d938755d6k.htm 6-K 16888
2 EX-1.1 d938755dex11.htm EX-1.1 227274
3 EX-3.1 d938755dex31.htm EX-3.1 301771
4 EX-5.1 d938755dex51.htm EX-5.1 27352
5 GRAPHIC g938755dsp0006.jpg GRAPHIC 2902
6 GRAPHIC g938755g0710192640783.jpg GRAPHIC 7690
  Complete submission text file 0001193125-20-191149.txt   589160
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 201023652
SIC: 2834 Pharmaceutical Preparations